MoU between IRIIC,UIU and ESB, Incepta Pharmaceuticals Ltd 

A tripartite Memorandum of Understanding (MoU) was signed among the Endometriosis-Adenomyosis Society of Bangladesh (ESB), Incepta Pharmaceuticals Ltd., and Institute of Research, Innovation, Incubation and Commercialization (IRIIC), United International University (UIU) for Industry-Academia Research Collaboration on 3rd August 2023. ESB, Incepta, and IRIIC, UIU will develop endometriosis and adenomyosis disease screening protocols and interventions using artificial intelligence.